| Health / Medical Topics |
Tucotuzumab Celmoleukin
A recombinant fusion protein comprised of a human monoclonal antibody directed against the epithelial cell adhesion molecule (EpCAM or KS) linked to an active interleukin-2 (IL2) molecule with potential antineoplastic activity. Tucotuzumab Celmoleukin recognizes and binds to EpCAM, a cell surface epithelial protein that is expressed on a wide variety of cancer cells, thereby concentrating IL2 in EpCAM-expressing tumor tissue. Subsequently, the localized IL2 moiety of the fusion protein may stimulate a cytotoxic T-cell antitumor immune response. (NCI Thesaurus)
YOU MAY ALSO LIKE
A commercial preparation, by Pfizer, containing witch hazel (Hamamelis virginiana) extract, with anti-pruritic activity. Witch hazel extract has been shown to inhibit…
A type of polyp that grows in the colon and other places in the gastrointestinal tract and sometimes in other parts of…
A benign ovarian epithelial tumor. It has been described in mice and rats and is rare in other animal species. Morphologically it…
A malignant ovarian epithelial tumor. It has been described in mice and rats and is characterized by marked pleomorphism, atypia, and an…
An antimitotic tubulin-binding agent with potential antineoplastic activity. Tubulin-binding agent SSR97225 binds to tubulin, arresting the cell cycle at the G2/M checkpoint…
Tubulin--tyrosine ligase (377 aa, ~43 kDa) is encoded by the human TTL gene. This protein is involved in the addition of tyrosine…
